ATE247456T1 - Puderförmige zusammensetzung zur nasalen anwendung - Google Patents

Puderförmige zusammensetzung zur nasalen anwendung

Info

Publication number: ATE247456T1
Authority: AT; Austria
Prior art keywords: water; absorbing; base material; drug; gel
Prior art date: 1996-02-27

Application number

AT97905398T

Other languages

English (en)

Inventor

Masahiko Dohi

Yoshihisa Nishibe

Yuji Makino

Original Assignee

Teijin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-27

Filing date

1997-02-26

Publication date

2003-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26378964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE247456(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-02-26 Application filed by Teijin Ltd filed Critical Teijin Ltd

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE247456T1 publication Critical patent/ATE247456T1/de

Links

239000000203 mixture Substances 0.000 title abstract 5
239000000843 powder Substances 0.000 title 1
239000000463 material Substances 0.000 abstract 7
239000003814 drug Substances 0.000 abstract 6
229940079593 drug Drugs 0.000 abstract 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
210000003928 nasal cavity Anatomy 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT97905398T 1996-02-27 1997-02-26 Puderförmige zusammensetzung zur nasalen anwendung ATE247456T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP3955396		1996-02-27
JP4107996		1996-02-28
PCT/JP1997/000541 WO1997031626A1 (en)	1996-02-27	1997-02-26	Powdery composition for nasal administration

Publications (1)

Publication Number	Publication Date
ATE247456T1 true ATE247456T1 (de)	2003-09-15

Family

ID=26378964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97905398T ATE247456T1 (de)	1996-02-27	1997-02-26	Puderförmige zusammensetzung zur nasalen anwendung

Country Status (13)

Country	Link
US (3)	US6881423B2 (de)
EP (1)	EP0943326B2 (de)
JP (1)	JP3634380B2 (de)
KR (1)	KR100568436B1 (de)
CN (1)	CN1155368C (de)
AT (1)	ATE247456T1 (de)
AU (1)	AU722319B2 (de)
CA (1)	CA2247191C (de)
DE (1)	DE69724272T3 (de)
DK (1)	DK0943326T4 (de)
ES (1)	ES2205177T5 (de)
PT (1)	PT943326E (de)
WO (1)	WO1997031626A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1155368C (zh) *	1996-02-27	2004-06-30	帝人株式会社	鼻腔给药的粉剂组合物
TWI243687B (en) *	1998-04-21	2005-11-21	Teijin Ltd	Pharmaceutical composition for application to mucosa
AU762145C (en)	1998-08-26	2005-03-17	Teijin Limited	Powdery pernasal compositions
DE69928563T2 (de) *	1998-12-09	2006-07-27	Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville	Abgeben von neurotropischen Wirkstoffen an das Zentralnervensystem
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
AR026073A1 (es)	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica acuosa que contiene ciclesonida
EP1348428B1 (de) *	2000-11-29	2009-01-14	Itoham Foods Inc.	Pulverzubereitungen und verfahren zu ihrer herstellung
GB2378383A (en) *	2001-06-06	2003-02-12	Gursharan Moonga	Nasal delivery of pharmaceutical compositions in powder form
JP4721212B2 (ja) *	2001-07-05	2011-07-13	株式会社新日本科学	インスリンの経鼻投与用組成物
IL161446A0 (en) *	2001-11-26	2004-09-27	Daiichi Suntory Pharma Co Ltd	Medicinal compositions for nasal absorption
EP1494732B1 (de)	2002-03-20	2008-01-30	MannKind Corporation	Inhalationsgerät
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US20080260838A1 (en) *	2003-08-01	2008-10-23	Mannkind Corporation	Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US7714011B2 (en) *	2002-09-13	2010-05-11	Zicam, Llc	Compositions to reduce congestion and methods for application thereof to the nasal membrane
US7638138B2 (en)	2003-02-21	2009-12-29	Translational Research, Ltd.	Compositions for nasal administration of pharmaceuticals
WO2004084859A2 (en)	2003-03-21	2004-10-07	Nastech Pharmaceutical Company Inc.	Nasal calcitonin formulations containing chlorobutanol
WO2004087243A1 (ja)	2003-03-27	2004-10-14	Bioactis Limited	鼻腔用粉末薬剤施薬装置
GB0315632D0 (en)	2003-07-04	2003-08-13	West Pharm Serv Drug Res Ltd	Pharmaceutical formulations
WO2006016530A1 (ja) *	2004-08-10	2006-02-16	Translational Research, Ltd.	速効性でかつ高い吸収性を可能とする経鼻投与用組成物
DK1786784T3 (da)	2004-08-20	2011-02-14	Mannkind Corp	Katalyse af diketopiperazinsyntese
CN104436170B (zh)	2004-08-23	2018-02-23	曼金德公司	用于药物输送的二酮哌嗪盐
US7115561B2 (en) *	2004-09-22	2006-10-03	Patterson James A	Medicament composition and method of administration
ES2399053T3 (es)	2004-10-11	2013-03-25	Nasaleze Patents Limited	Composiciones para administración intranasal
GB2420707A (en) *	2004-10-11	2006-06-07	Nasaleze Patents Ltd	Compositions for intranasal administration
WO2006040596A2 (en) *	2004-10-11	2006-04-20	Nasaleze Ppm Limited	Compositions for intranasal administration
WO2007022345A2 (en) *	2005-08-17	2007-02-22	Fleming And Company, Pharmaceuticals	Vitamin b12 nasal spray and method of use
WO2007025286A2 (en) *	2005-08-26	2007-03-01	The Board Of Trustees Of The Leland Stanford Junior University	Therapy procedure for drug delivery for trigeminal pain
AU2006290227B2 (en)	2005-09-14	2012-08-02	Mannkind Corporation	Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
KR20080096809A (ko)	2006-02-22	2008-11-03	맨카인드 코포레이션	디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
ES2652415T3 (es)	2006-12-26	2018-02-02	Shin Nippon Biomedical Laboratories, Ltd.	Preparación para aplicación transnasal
KR101736502B1 (ko) *	2007-10-24	2017-05-16	맨카인드 코포레이션	Ｇｌｐ-1에 의한 유해 효과의 예방 방법
SG10201507036TA (en)	2008-06-13	2015-10-29	Mannkind Corp	A dry powder inhaler and system for drug delivery
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
EP2609954B1 (de)	2008-06-20	2021-12-29	MannKind Corporation	Interaktives Gerät für die Echtzeit-Profilierung von Inhalationsversuchen
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
MX2011009512A (es)	2009-03-11	2011-11-29	Mannkind Corp	Aparato, sistema y metodo para medir la resistencia de un inhalador.
EP2429495A4 (de) *	2009-05-15	2014-01-22	Shin Nippon Biomedical Lab Ltd	Intranasale pharmazeutische zusammensetzung mit verbesserter pharmakokinetik
MY157166A (en)	2009-06-12	2016-05-13	Mankind Corp	Diketopiperazine microparticles with defined specific surface areas
GB2472327B (en) *	2009-07-31	2013-03-13	Shin Nippon Biomedical Lab Ltd	Intranasal granisetron and nasal applicator
CN102482358B (zh) *	2009-09-02	2014-12-10	日本曹达株式会社	羟丙基纤维素粒子
ES2623328T3 (es) *	2009-09-18	2017-07-11	Sitec Pharmabio Sl	Procedimiento para la deshidratación de productos en polvo
CA2778698A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
WO2011115264A1 (ja)	2010-03-19	2011-09-22	第一三共株式会社	経鼻投与用組成物及びその製造方法
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
EP2694402B1 (de)	2011-04-01	2017-03-22	MannKind Corporation	Blisterverpackung für pharmakartuschen
SE536091C2 (sv)	2011-04-14	2013-04-30	Pep Tonic Medical Ab	Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
US20130045958A1 (en)	2011-05-13	2013-02-21	Trimel Pharmaceuticals Corporation	Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en)	2011-05-13	2017-09-12	Acerus Pharmaceuticals Srl	Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130040923A1 (en)	2011-05-13	2013-02-14	Trimel Pharmaceuticals Corporation	Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
HK1200318A1 (en)	2011-10-24	2015-08-07	曼金德公司	Methods and compositions for treating pain
JP5717658B2 (ja) *	2012-01-13	2015-05-13	シスメックス株式会社	副腎皮質刺激ホルモンの検出方法および吸着剤
US9789071B2 (en)	2012-06-27	2017-10-17	G2B Pharma, Inc.	Intranasal formulation of epinephrine for the treatment of anaphylaxis
EP2872205B1 (de)	2012-07-12	2017-02-08	MannKind Corporation	System zur verabreichung von arzneimitteln in trockenpulverform
US10159644B2 (en)	2012-10-26	2018-12-25	Mannkind Corporation	Inhalable vaccine compositions and methods
AU2014226192B2 (en) *	2013-03-04	2018-07-26	Besins Healthcare Luxembourg Sarl	Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
US11744838B2 (en)	2013-03-15	2023-09-05	Acerus Biopharma Inc.	Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
WO2014144895A1 (en)	2013-03-15	2014-09-18	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
KR102465025B1 (ko)	2013-07-18	2022-11-09	맨카인드 코포레이션	열-안정성 건조 분말 약제학적 조성물 및 방법
EP3030294B1 (de)	2013-08-05	2020-10-07	MannKind Corporation	Insufflationsvorrichtung
CA2923270A1 (en) *	2013-09-03	2015-03-12	Shin Nippon Biomedical Laboratories Ltd. (Snbl)	Intranasal formulation for the treatment of cardiopulmonary resuscitation (cpr), cardiac life support (cls), anaphylaxis and/or anaphylactoid reactions
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
US11389473B2 (en)	2015-01-07	2022-07-19	Tonix Pharmaceuticals Holding Corp.	Magnesium-containing oxytocin formulations and methods of use
MX2018012351A (es)	2016-04-12	2019-02-07	Trigemina Inc	Formulaciones de oxitocina que contienen magnesio y metodos de uso.
US11744967B2 (en)	2017-09-26	2023-09-05	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal delivery devices
AU2018371435B2 (en) *	2017-11-27	2023-12-14	Aska Pharmaceutical Co., Ltd.	Powder preparation for nasal administration
CN108158978A (zh) *	2018-03-26	2018-06-15	厦门传福堂药业有限公司	一种高分子水性凝胶及其制备方法和用途
EP3970696A4 (de) *	2019-05-16	2023-03-01	Shin Nippon Biomedical Laboratories, Ltd.	Pulverpräparat zur transnasalen verabreichung und herstellungsverfahren dafür
US12564210B2 (en)	2020-12-16	2026-03-03	Liw Innovation Ab	Powder composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6034925B2 (ja) †	1979-07-31	1985-08-12	帝人株式会社	持続性鼻腔用製剤およびその製造法
JPS607965B2 (ja) *	1980-08-07	1985-02-28	帝人株式会社	鼻腔粘膜投与用粉剤の製造法
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
JPS6032714A (ja) *	1983-08-01	1985-02-19	Teijin Ltd	鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
EP0187433B1 (de)	1983-08-01	1990-12-27	Teijin Limited	Pulverige pharmazeutische Zusammensetzung zur Anwendung auf die Schleimhaut der Mund- oder Nasenhöhle
JPS6034925A (ja)	1983-08-04	1985-02-22	Mitsubishi Chem Ind Ltd	２−ヒドロキシイソフタルアルデヒド類の製造法
JPS60224616A (ja) *	1984-04-24	1985-11-09	Teijin Ltd	経鼻投与用組成物
JPS6242888A (ja)	1985-08-21	1987-02-24	カシオ計算機株式会社	太陽電池を備えたｉｃカ−ド
GB2193891B (en)	1986-08-18	1990-07-25	Sandoz Ltd	Nasal pharmaceutical composition containing a somatostatin anologue.
JP3068924B2 (ja)	1990-11-29	2000-07-24	旭硝子株式会社	熱線遮断膜
DE69222295T2 (de)	1992-05-26	1998-04-09	The Procter & Gamble Co., Cincinnati, Ohio	Pulverförmige pharmazeutische Zusammensetzung
DE69330672T2 (de) *	1992-06-12	2002-06-27	Teijin Ltd., Osaka	Pharmazeutische zubereitung zur anwendung in den atemwegen
ATE215377T1 (de)	1993-07-30	2002-04-15	Teijin Ltd	Pulver zur nasalen verabreichung peptidischer oder proteinischer arzneistoffe
JPH07242550A (ja)	1994-03-02	1995-09-19	Teijin Ltd	二次性副甲状腺機能亢進症治療剤
CN1155368C (zh) *	1996-02-27	2004-06-30	帝人株式会社	鼻腔给药的粉剂组合物

1997
- 1997-02-26 CN CNB97193861XA patent/CN1155368C/zh not_active Expired - Fee Related
- 1997-02-26 DK DK97905398T patent/DK0943326T4/da active
- 1997-02-26 ES ES97905398T patent/ES2205177T5/es not_active Expired - Lifetime
- 1997-02-26 US US09/125,814 patent/US6881423B2/en not_active Expired - Fee Related
- 1997-02-26 PT PT97905398T patent/PT943326E/pt unknown
- 1997-02-26 JP JP53078797A patent/JP3634380B2/ja not_active Expired - Fee Related
- 1997-02-26 WO PCT/JP1997/000541 patent/WO1997031626A1/ja not_active Ceased
- 1997-02-26 CA CA002247191A patent/CA2247191C/en not_active Expired - Fee Related
- 1997-02-26 AU AU22302/97A patent/AU722319B2/en not_active Ceased
- 1997-02-26 AT AT97905398T patent/ATE247456T1/de active
- 1997-02-26 KR KR1019980706662A patent/KR100568436B1/ko not_active Expired - Fee Related
- 1997-02-26 DE DE69724272T patent/DE69724272T3/de not_active Expired - Lifetime
- 1997-02-26 EP EP97905398A patent/EP0943326B2/de not_active Expired - Lifetime
2004
- 2004-06-04 US US10/860,058 patent/US7731990B2/en not_active Expired - Fee Related
2009
- 2009-11-02 US US12/610,901 patent/US8206748B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0943326B2 (de)	2006-12-20
ES2205177T3 (es)	2004-05-01
PT943326E (pt)	2003-12-31
EP0943326A4 (de)	2000-12-20
DK0943326T4 (da)	2007-01-22
AU2230297A (en)	1997-09-16
KR19990087261A (ko)	1999-12-15
ES2205177T5 (es)	2007-08-01
US7731990B2 (en)	2010-06-08
DE69724272T2 (de)	2004-06-09
CN1155368C (zh)	2004-06-30
KR100568436B1 (ko)	2007-04-25
JP3634380B2 (ja)	2005-03-30
CA2247191C (en)	2005-01-04
CA2247191A1 (en)	1997-09-04
EP0943326B1 (de)	2003-08-20
US20020012688A1 (en)	2002-01-31
WO1997031626A1 (en)	1997-09-04
US20100047206A1 (en)	2010-02-25
US20040219108A1 (en)	2004-11-04
AU722319B2 (en)	2000-07-27
CN1216464A (zh)	1999-05-12
DE69724272T3 (de)	2007-05-10
US8206748B2 (en)	2012-06-26
EP0943326A1 (de)	1999-09-22
US6881423B2 (en)	2005-04-19
DK0943326T3 (da)	2003-12-08
DE69724272D1 (de)	2003-09-25

Legal Events

Date

Code

Title

Description

2004-05-15

UEP

Publication of translation of european patent specification

Ref document number: 0943326

Country of ref document: EP

2007-03-15

UEP